Disseminierte intravasale Gerinnung (DIC) und Verbrauchskoagulopathie

P. Ostendorf; K. Jaschonek; W. Daiß

doi:10.1055/s-0038-1655100

Hämostaseologie, Inhaltsverzeichnis

Hamostaseologie 1985; 05(02): 44-53
DOI: 10.1055/s-0038-1655100

Originalarbeiten

Schattauer GmbH

Disseminierte intravasale Gerinnung (DIC) und Verbrauchskoagulopathie

Sepsis und Schock

P. Ostendorf

¹Medizinische Universitäts-Klinik, Abt. II (Direktor: Prof. Dr. H. D. Waller), Tübingen

,

K. Jaschonek

¹Medizinische Universitäts-Klinik, Abt. II (Direktor: Prof. Dr. H. D. Waller), Tübingen

,

W. Daiß

¹Medizinische Universitäts-Klinik, Abt. II (Direktor: Prof. Dr. H. D. Waller), Tübingen

› Institutsangaben

Abstract

Zusammenfassung

Die Vorstellung zur Pathogenese der disseminierten intravasalen Gerinnung, die Beziehung zwischen Verbrauchskoagulopathie und disseminierter Thrombosierung der Mikrozirkulation und die resultierenden Symptomkomplexe von Blutung, Hyperfibrinolyse, Organschädigung, Hämolyse und Azidose sind in Abb. 7 als Zusammenfassung dieser Arbeit gegenübergestellt.

Volltext

Referenzen

LITERATUR
1 Nauyn B. Untersuchungen über Blutgerinnung I. M. lebender Tiere und ihre Folgen. Arch. Exp. Pathol. Pharmak. 01: 1 1873;
2 Foä P, Pellacani P. Sul fermento fibrinogeno. Sülle azioni tossiche, exercitate da alcuni organi freschi. Arch. Sci. Med. 07: 113 1884;
3 Lasch H. G, Krecke H-J, Rodriguez-Erdmann F, Sessner H. H, Schütterle G. Verbrauchskoagulopathien (Pathogenese und Therapie). Folia haematologica N. F. 06: 325-330 1961;
4 McKay D. G. Disseminated intravascular coagulation. Harper & Row; New York: 1965
5 Hardaway R. M. Syndromes of disseminated intravascular coagulation. With Special Reference to Shock and Hemorrhage. Thomas, Springfield: 1966
6 Müller-Berghaus G. Aktivierung der Blutgerinnung bei Sepsis durch gram-negative Bakterien. In: Deutsch E, Lechner K. (Hrsg.): Fibrinolyse, Thrombose, Hämostase. Schattauer, Stuttgart; New York: 1980. 166 ff.
7 Colman R. W. Surface-mediated defense reactions. The Plasma Contact Activation System. J. Clin. Invest. 73: 1249-1253 1984;
8 Niewiarowski S, Stuart R. K, Thomas D. P. Activation of intravascular coagulation by collagen. Proc. Soc. Exp. Biol. Med. 123: 196 1966;
9 Wilner G. D, Nossel H. L, Le Roy E. D. Activation of Hageman factor by collagen. J. Clin. Invest. 47: 2608-2615 1968;
10 Morrison D. C, Cochrone C. G. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins). J. Exp. Med. 140: 797 1974;
11 Mason J. W, Colman R. W. The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia or liver disease. Thromb. Diath. Haemorrh. 26: 325-331 1971;
12 Mason J. W, Kleeberg U, Dolan P, Colman R. W. Plasma kallikrein and Hageman factor in gram-negative bacteremia. Ann. Int. Med. 73: 545-551 1970;
13 Heinrich D. Sepsis und Blutgerinnung (Sepsis aus der Sicht des Hämostaseologen). Beitr. Infusionstherapie klin. Ernähr. 10: 25-41 1983;
14 Gurewich V, Nunn T, Lipinski B. Activation of intrinsic or extrinsic blood coagulation in experimental venous thrombosis and disseminated intravascular coagulation: Pathogenetic differences. Thromb. Res. 14: 931-940 1979;
15 Radcliffe R, Nemerson Y. Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa. J. Biol. Chem. 251: 4797-4800 1976;
16 Radcliffe R, Bagdasarian A, Colman R, Nemerson Y. Activation of bovine factor VII by Hageman factor fragments. Blood 50: 611-617 1977;
17 Nemerson Y. Regulation of the initiation of coagulation by factor VII. Haemostasis 13: 150-155 1983;
18 Osterud B. Activation pathways of the coagulation system in normal haemostasis. Scand. J. Haematol 32: 337-345 1984;
19 Maynard J. R, Dreyer B. G, Stemerman M. E, Pitlick F. A. Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts. Blood 50: 387-396 1977;
20 Gralnick H. R, Abrell E. Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukaemia. Brit. J. Haematol. 24: 89 1973;
21 Pineo G. F, Regoeczi E, Hatton M. W. C, Brain M. C. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. J. Lab. Clin. Med. 82: 255-266 1973;
22 Gordon S. G, Franks J. J, Lewis B. Cancer procoagulant A: A factor X activating procoagulant from malignant tissue. Thromb. Res. 06: 127-137 1975;
23 Ostendorf P. Pathogenese venöser Thrombosen. In: Tscherne H, Deutsch E. (Hrsg.): Postoperative Thromboembolie-Prophylaxe aus aktueller Sicht. Thieme, Stuttgart; New York: 1981: 18-31.
24 Osterud B, Rapaport S. I. Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation. Proc. Natl. Acad. Sci. 74: 5260-5264 1977;
25 Franza B. R, Aronson D. L, Finlayson J. B. Activation of human prothrombin by procoagulant factor from the venom of echis carinatus. J. Biol. Chem. 250: 7057 1975;
26 Weiss H. J, Allan S, Davidson E, Kochwa S. Afibrinogenemia in man following the bite of a rattlesnake (crotalus adamanteus). Amer. J. Med. 47: 625-634 1969;
27 Ostendorf P. Klinische und experimentelle Untersuchungen zur Pathogenese der Schocklunge. Habilitationsschrift, Tübingen: 1977
28 Brox J. H, Osterud B, Bjorklid E, Fenton J. W. Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets. Brit. J. Haematol. 57: 239-246 1984;
29 Niemetz J. Coagulant activity of leukocytes: Tissue factor activity. J. Clin. Invest. 51: 307-313 1972;
30 Muhlfelder T. W, Khan I, Niemetz J. Factors influencing the release of procoagulant-tissue factor activity from leucocytes. J. Lab. Clin. Med. 92: 65-72 1978;
31 Miiller-Berghaus G, Bohn E, Höbel W. Activation of intravascular coagulation by endotoxin: the significance of granulocyte and platelets. Brit. J. Haematol. 33: 213-220 1976;
32 Lipinski B, Gurewich V. The effect of leukopenia versus thrombocytopenia on endotoxin induced intravascular coagulation. Thromb. Res. 08: 403-411 1976;
33 Rivers R. P. A, Hathaway W. E, Weston W. L. The endotoxin-induced coagulant activity of human monocytes. Brit. J. Haemat. 30: 311-316 1975;
34 Hiller E, Saal J. G, Ostendorf P, Griffiths J. W. The procoagulant activity of human granulocytes, lymphocytes and monocytes stimulated by endotoxin. Klin. Wschr. 55: 751-757 1977;
35 Van Ginkel C. J. W, Zeiglemaker W. P, Strieker L. A. M. Enhancement of monocyte thromboplastin activity by antigenically stimulated lymphocytes: A link between immune reactivity and blood coagulation. Eur. J. Immunol. 11: 579-583 1981;
36 Levy G. A, Schwartz B. S, Edgington T. S. The existence of T helper (Tì) and T suppressor (Tã) cells for the generation of monocyte thromboplastin activity by lipopolysaccharides. Thromb. Haemostasis. 46: 302 1981; Abstr. 0945.
37 Carson S. D. Tissue factor-initiated blood coagulation. Progr. in Clin. Pathol. 09: 1-14 1984;
38 Osterud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: Related to an unfavourable prognosis. Thromb. Haemost. 49: 5-7 1983;
39 Ostendorf P, Mittermayer C. hr. Bedeutung der Mikroembolien für die Entstehung der Schocklunge. In: Marx R, Thies H. A. Lunge, Blutgerinnung und Hämostase. Editiones Roche, Basel; 1981: 175-186.
40 Abraham E, Bland R. D, Cobo J. C, Shoemaker W. C. Sequential cardiorespiratory patterns associated with outcome in septic shock. Chest. 85: 75-80 1984;
41 Brigham K. L, Begley C. J, Bernard G. R, Hutchinson A. A, Loyd J. E, Lucht W. D, Meyrick B, Newman J. H, Niedermeyer M. E, Ogletree M. L, Sheller J. R, Snapper J. R. Septicemia and lung injury. Clin. Labor. Med. 03: 719-744 1983;
42 Cooper J. A, Solano S. J, Bizios R, Kaplan J. E, Malik A. B. Pulmonary neutrophil kinetics after thrombin-induced intravascular coagulation. J. Appl. Physiol.: Respirat. Environ. Exer. Physiol. 57: 826-832 1984;
43 Heflin A. C, Brigham K. L. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J. Clin. Invest. 68: 1253-1260 1981;
44 Kramer W, Müller-Berghaus G. Effect of platelet antiserum on the activation of intravascular coagulation by endotoxin. Thromb. Res. 10: 47-70 1977;
45 George J. N, Nurden A. T, Phillips D. R. Molecular defects in interactions of platelets with the vessel wall. New Engl. J. Med. 311: 1084-1098 1984;
46 Lüscher E. F. The role of blood cells and of the vessel wall in the induction of intravascular coagulation. Klin, Wschr. 60: 710-712 1982;
47 Carmona R. H, Tsao T. C, Trunkey D. D. The role of prostacyclin and thromboxane in sepsis and septic shock. Arch. Surg. 119: 189-192 1984;
48 Ditter H, Matthias F. R, Reitz D. Auswirkungen einer Infusion von Prostazyklin (PGI₂) auf die Plättchenzahl und den Prostaglandinstoffwechsel der Plättchen während des experimentellen Endotoxinschocks. Verh. Dtsch. Ges. Inn. Med. 89: 1120-1124 1983;
49 Fletcher J. R. Prostaglandin-SynthetaseInhibitors in Endotoxin or Septic Shock A Review. Adv. Shock Res. 10: 9-14 1983;
50 Reines H. D, Halushka P. V, Cook J. A, Wise W. C, Rambo W. Plasma thromboxane concentrations are raised in patients dying with septic shock. Lancet. II: 174-175 1982;
51 Webb P. J, Westwick J, Scully M. F, Zahavi J, Kakkar V. V. Do prostacyclin and thromboxane play a role in endotoxic shock? Brit. J. Surg. 68: 720-724 1981;
52 Miiller-Berghaus G, Lohmann E. The role of complement in endotoxin-induced disseminated intravascular coagulation: studies in congenitally C₆-deficient rabbits. Brit. J. Haemat. 28: 403 1974;
53 Osterud B, Eskeland T. The mandatory role of complement in the endotoxininduced synthesis of tissue thromboplastin in blood monocytes. FEBS Letts. 149: 75-79 1982;
54 Ostendorf P, Freund M. Pneumokokkenvakzine nach Splenektomie? Zur Pathogenese und Prophylaxe der OPSI (Overwhelming Post-Splenectomy-Infection). Internist. 22: 171-174 1981;
55 Mosher D. F, Williams E. M. Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. J. Lab. Clin. Med. 91: 729-735 1978;
56 McKay D. G, Müller-Berghaus G. Therapeutic implications of disseminated intravascular coagulation. Amer. J. Cardiol. 20: 392-410 1967;
57 Nossel H. L, Wasser J, Kaplan K. L. et al. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline. J. Clin. Invest. 64: 1371-1378 1979;
58 Freund M, Ostendorf P, Gärtner V. H, Tidow S. OPSI - Ein Fall foudroyant verlaufender Sepsis. Internist. 22: 175-179 1981;
59 Freund M, Ostendorf P, Hiller E. Ein Fall von Clostridienbakteriämie mit Verbrauchskoagulopathie. Internist. 22: 514-517 1981;
60 Kirchner C. W, Reheis C. E. Two serious complications of neoplasia: Sepsis and disseminated intravascular coagulation. Nursing Clinics of North America. 17: 595-606 1982;
61 Edwards R. L, Rickles F. R, Cronlund M. Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation. J. Lab. Clin. Med. 98: 917-928 1981;
62 Romero R, Duffy T. P, Berkowitz R. L, Chang E, Hobbins J. C. Prolongation of a preterm pregnancy complicated by death of a single twin in utero and disseminated intravascular coagulation. Effects of treatment with heparin. New Engl. J. Med. 310: 772-774 1984;
63 Müller-Berghaus G, Lasch H-G. Microcirculatory disturbances induced by generalized intravascular coagulation. In: Handbook of Experimental Pharmacology XVI/3. Springer, Berlin, Heidelberg; New York: 1975: 429-514.
64 Tate R. M, Repine J. E. Neutrophils and the adult respiratory distress syndrome. Amer. Rev. Resp. Dis. 128: 552-559 1983;
65 Staub N. C, Schultz E. L, Albertine K. H. Leucocytes and pulmonary microvascular injury. Ann. N. Y. Acad. Sci. 384: 332-342 1982;
66 Malik A. B, Johnson A, Tahamont M. V. Mechanisms of lung vascular injury after intravascular coagulation. Ann. N. Y. Acad. Sci. 384: 213-234 1982;
67 v. Tahamont M, Malik A. B. Granulocytes mediate the increase in pulmonary vascular permeability after thrombin embolism. J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 54: 1489-1495 1983;
68 Ostendorf P, Birzle H, Vogel W, Mittermayer C. h. Pulmonary radiographic abnormalities in shock. Roentgenclinical pathological correlation. Radiology 115: 257-263 1975;
69 Heene D. L, Kirchstein W. Nachweis von Fibrinderivaten im Plasma bei Sepsis. In: Deutsch E, Lechner K. (Hrsg.): Fibrinolyse, Thrombose, Hämostase. Schattauer, Stuttgart; New York: 1980: 169-174.
70 Heene D. L, Lasch H. G, Matthias F. R. Gerinnungsstörungen und Verbrauchskoagulopathie bei polytraumatisierten Patienten. Intensivbehandlung 01: 42-48 1976;
71 Thaler E. Verhalten der Inhibitoren der Blutgerinnung und Fibrinolyse bei Sepsis. In: Deutsch E, Lechner K. (Hrsg.): Fibrinolyse, Thrombose, Hämostase. Schattauer, Stuttgart; New York: 1980. 179ff.
72 Lämmle B, Tran T. H, Ritz R, Duckert F. Plasma prekallikrein, factor XII, antithrombin III, C⁻ ₁-inhibitor and á₂-macroglobulin in critically III patients with suspected disseminated intravascular coagulation (DIC). Amer. J. Clin. Pathol. 82: 396-404 1984;
73 Gardiner J. E, Griffin J. H. Human protein C and thromboembolic disease. Progr. Hematol 12: 265-278 1981;
74 Bick L, Dukes M. L, Wilson W. L, Fekete L. F. Antithrombin III (AT-III) as a diagnostic aid in disseminated intravascular coagulation. Thrombosis Res. 10: 721-729 1977;